• Voir la page en français

Innovative Medical and Surgical Devices

The CTTM transforms ideas, research results and new knowledge into innovative solutions, products and devices for patients.

Treatment for bioartificial pancreas (Mailpan®)

With the CeeD and Statice companies, the CTTM has co-invented the macroencapsulation device for pancreatic islets or Mailpan® bioartificial pancreas.

The CTTM has developed, designed and now produces the semi-permeable membrane treatment that composes the device's structure

The treatment purpose is for the membrane to be implanted under the best safety and performance conditions:

  • Cells colonization control
  • Preserved porosity
  • Bioactivity: revascularization, limited inflammation

The CTTM is the co-founder of the start-up Defymed, which will carry on the clinical investigations and will sell the bioartifical pancreas.


"Research that has changed our lives". Report by Sophie Bécherel (France Inter)